BioLASCO Taiwan Co., Ltd.

6662

TW0006662000

Biotechnology & Medical Research

End-of-day quote Taipei Exchange Other stock markets 03:30:00 27/06/2024 am IST			5-day change	1st Jan Change
37.4 ^TWD	-0.13%		+1.08%	+12.65%

14/05	BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
20/03	BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

BioLASCO Taiwan Co., Ltd. Announces Resignation of Chen,Chien-Chang as Director

March 03, 2021 at 03:30 pm IST

BioLASCO Taiwan Co., Ltd. announced the resignation of Chen,Chien-Chang as Director.

Latest news about BioLASCO Taiwan Co., Ltd.

BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	14/05	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	20/03	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	09/11	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	08/23/08	CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend	31/23/31	CI
BioLASCO Taiwan Co., Ltd. Announces Change of Remuneration Committee	12/23/12	CI
BioLASCO Taiwan Co., Ltd. Announces Change of Audit Committee	12/23/12	CI
BioLASCO Taiwan Co., Ltd. Announces Board Changes	12/23/12	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/23/15	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/23/24	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	04/22/04	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	05/22/05	CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on August 26, 2022	05/22/05	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	05/22/05	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	24/22/24	CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	06/21/06	CI
BioLASCO Taiwan Co., Ltd. Announces CEO Changes	05/21/05	CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021	06/21/06	CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on September 22, 2021	05/21/05	CI
BioLASCO Taiwan Co., Ltd. Elects Liu, Wei-Ming as Natural-Person Director	05/21/05	CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020	26/21/26	CI
BioLASCO Taiwan Co., Ltd. Appoints Stacey Yu as Corporate Governance Officer	25/21/25	CI
BioLASCO Taiwan Co., Ltd. Renews Ten-Year Distribution and Propagation Agreement with Charles River Laboratories International, Inc	18/21/18	CI
BioLASCO Taiwan Co., Ltd. Announces Resignation of Chen,Chien-Chang as Director	03/21/03	CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020	12/20/12	CI

Chart BioLASCO Taiwan Co., Ltd.

Duration

Period

More charts

BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
BIOLASCO TAIWAN CO., LTD.	+12.65%	29.42M
MODERNA, INC.	+21.51%	46.93B
LONZA GROUP AG	+37.63%	39.08B
IQVIA HOLDINGS INC.	-8.42%	38.48B
ALNYLAM PHARMACEUTICALS, INC.	+29.12%	31.01B
CELLTRION, INC.	-13.75%	26.14B
ICON PUBLIC LIMITED COMPANY	+11.12%	25.88B
MEDPACE HOLDINGS, INC.	+35.97%	12.53B
BIO-TECHNE CORPORATION	-6.66%	11.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-12.44%	10.65B